Thu, May 9, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Industry Updates

Zeal Capital Partners hires NEA's Zhen to lead healthcare vertical

Thursday, August 31, 2023
Opalesque Industry Update - Zeal Capital Partners, the Washington, D.C.-based venture capital firm, today announced its expanded commitment into health equity. Healthcare investor Emily Zhen joins Zeal Capital Partners as Principal to execute Zeal's new health equity investing mandate. Zeal aims to narrow healthcare disparities by investing in tech-enabled, early-stage healthcare businesses that are delivering care to traditionally overlooked populations.

"Zeal Capital Partners continues to pursue our north star of narrowing the wealth and skills gaps, especially for disadvantaged communities. We recognize that better health outcomes are critical to ensuring that all individuals can equitably participate in the economy," said Nasir Qadree, Founder and Managing Partner, Zeal Capital Partners. "We are motivated by the entrepreneurial opportunity to disrupt systems and remediate the systemic disparities in healthcare. Emily will be an invaluable contributor on our team as we spearhead the launch of our new health equity vertical. She brings multi-stage investing, operating, and research experience in healthcare."

The U.S. spends over $4 trillion on healthcare per year. While the pandemic dramatically accelerated healthcare innovation, it also highlighted longstanding inequities and disparities among underserved populations. Zhen will lead the end-to-end investment process for seed and Series A stage companies tackling access and affordability of care, women's health, mental health and wellness, and social determinants of health. She will also work with Zeal's Investment team on deal execution across the existing financial technology and future of work and learning categories.

"I am driven to improve the quality, access, and affordability of healthcare for all," said Emily Zhen. "I'm thrilled to join the Zeal team to lead the new health equity investing practice. At Zeal, we believe health is a crucial building block to wealth and economic mobility. I look forward to partnering with innovative founders, diverse management teams, and our limited partners to address equity of access, affordability, and outcomes in healthcare."

Prior to joining Zeal, Zhen served as a healthcare investor at New Enterprise Associates (NEA), a global venture capital and growth equity firm. At NEA, she helped deploy over $500 million in capital, incubated portfolio companies from ideation through growth stage, and facilitated public offerings and follow-on financings. Before joining NEA, Zhen was a member of the healthcare investment banking team at Goldman Sachs. She has also worked for digital health startups, the U.S. Treasury, and in life sciences research. Zhen graduated summa cum laude from the University of Pennsylvania, with a BA in Biology, a BS in Economics from the Wharton School, and a certificate in health policy.

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1